Jump to section
To develop a way for pharmaceutical, biotech, and medical device companies to gather the insights that drive innovation and deliver powerful results for their business and life-changing results for patients around the world.
Within3 is a platform that helps those working in pharmaceuticals, medical practices, and for hospitals to make informed decisions in their work. From research and development to commercialization, the analytics platform reviews and identifies data from medical affairs, commercial, internal and payer groups to help navigate the industry.
Fast-acting results have become more and more vital for this industry in recent years, and as a result Within3 have attracted serious funding. This will be invested in global expansion and product development which will be crucial as they continue to meet the growing demand from the market.
Within3 is already used by the top 20 pharmaceutical companies and have customers in over 150 countries. By having such a strong need for the product combined with significant financial backing, Within3 is well set to see continued success.

Freddie
Company Specialist at Welcome to the Jungle
Sep 2020
$100m
GROWTH EQUITY VC
Dec 2012
$20m
GROWTH EQUITY VC
This company has top investors
Erin Mistry
(CEO)Alongside serving as Within3's CEO, Erin is part of the Harvard T.H. Chan School of Public Health Executive Council, as well as the co-founder and CEO of SNAP Life Sciences. They are also a Board Member at FACCNE, ACCESS Forum and Incubate Coalition.